Item added to your cart
Some pet parents have had this moment recently. They open the bag of their dog's trusted supplement. Something feels off. The texture. The smell. The customer service line that doesn't pick up like it used to. They search online. Others noticed too. The brand got acquired.
We're writing this because we've seen it happen in our own category, and because we want to be direct about where Plentum stands.
We are not for sale. We are not looking to be acquired. We are staying independent because the moment we answer to shareholders is the moment your dog's health becomes a line item.
This isn't about sentiment. It's about science.
When a wellness brand gets absorbed into a large corporate structure, the first things that face pressure are the things that cost the most to do right: premium ingredient sourcing, third-party testing, slow-cycle clinical research, and the willingness to reformulate when the science says to, even when the current formula is profitable.
Acquisition math is simple and merciless. A parent company pays hundreds of millions for a pet supplement brand. That investment has to return. The fastest lever is margin. Margin comes from reducing COGS, the cost of goods sold. Ingredients are COGS. Testing is overhead. Transparency is a risk management problem, not a brand value.
The result is what you've already seen. Customers report changed formulas. Service degrades. The promise the brand was built on quietly erodes. The pet supplement industry has seen this pattern play out publicly. The FDA maintains an active recall database for pet products, including multiple Salmonella-related recalls affecting established brands in recent years. The National Animal Supplement Council has spent two decades pushing the industry toward transparent claims, quality audits, and NASC Quality Seal programs — and the brands that stay independent are the ones most aligned with those standards.
At Plentum, our formulation decisions aren't reviewed by a board in a boardroom that's never met a dog. They're driven by one question: does this work for dogs, and can we prove it? That's a question we can only keep asking freely if we stay independent.
Every Plentum formula is built on ingredient science first. We don't start with a margin target and reverse-engineer the formula. We start with the biology, specifically what the canine microbiome actually needs, and build from there.
Our Patent-Pending Oral health postbiotic formula is not a marketing badge. It's a proprietary approach to nutrient delivery that accounts for canine gut transit time, pH levels, and strain specificity in a way that generic blends don't. It took us years to get right, and we're still refining it.
We use Clinically Studied ingredients with documented bioavailability data in dogs, not ingredient deck line items chosen because they photograph well on a label. Every batch goes through third-party testing. The Certificates of Analysis are not internal documents. They exist. They're available.
We publish what's actually in every product. Not the claim on the label. The actual amounts, from actual testing.
This matters because the gap between what a label claims and what a product contains is one of the most persistent problems in the pet supplement industry. We've seen class actions filed over products that allegedly contained a fraction of the advertised amount of a key ingredient. We've seen federal courts issue injunctions against brands making unsupported category leadership claims. We've seen contamination reports from third-party labs contradict manufacturer claims, including FDA-documented Salmonella recalls affecting multiple SKUs from established brands.
We have one policy on this: show the work. If it's in the formula, it shows up in testing. If it doesn't show up in testing, it doesn't go in the formula. That policy is much easier to maintain when you don't have a quarterly earnings call to prepare for.
The gut health space is evolving fast. What we understood about the canine microbiome five years ago is already being refined by new research on strain specificity, on the emerging role of postbiotics, on the relationship between gut health and immune function, anxiety, joint inflammation, and longevity. The Integrative Veterinary Care Journal and Frontiers in Veterinary Science publish ongoing microbiome research that directly informs how a modern dog supplement should be built.
An independent brand can follow the science wherever it leads. A brand owned by a conglomerate follows the science as far as it's profitable to follow it, then stops. Our Microbiome-First approach means we're not locked into a legacy formula just because it's what we launched with. When the science improves, the formula improves.
Concrete things. Not philosophy.
You get the same formula you trusted last month. No quiet reformulations driven by cost-cutting. No ingredient swaps disguised behind updated packaging language.
You get honest labels. The number on the front matches what's in the batch. The third-party Certificate of Analysis matches the label. There's no gap to hide.
You get a customer service line staffed by people who know the product. Not a phone that goes to voicemail. Not a callback that doesn't come. Not a ticket system that times out after 72 hours.
You get research that's ongoing. Not a formula frozen in amber because margin pressure has made reformulation too costly.
You get a brand that can change its mind when the science says to. That's what Microbiome-First means in practice: the dog's biology is the authority. Not the margin deck. Not the investor deck. The dog.
We are a founder-led, independent, science-first dog wellness company. We are not looking for a buyer. We are not building toward an exit. We are building a company that can still make the same promises to your dog in ten years that we're making today.
The pet supplement market is growing fast. Big companies are paying big money to get into it. The pressure to sell is real in this industry, and we understand why founders take those calls.
We've made our decision. The answer is no.
If you want a supplement backed by Patent-Pending oral health postbiotic science, Clinically Studied ingredients, and a company that's never going to quietly change the formula to hit a margin target, that's us.
Plentum is independently owned and operated. Our formulas are developed in-house, manufactured under third-party verified quality standards, and tested by independent laboratories. We do not make drug claims. Clinically Studied refers to ingredients with documented research in peer-reviewed literature.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Some pet supplement brands got acquired and customers noticed the formula change. Here is why Plentum is staying independent, founder-led, and answers to dogs not shareholders.
